Clinical Trial Details

NCT ID: NCT02783573
Date Last Changed: October 18, 2017

Overview

Research Study Summary

A Phase 3 clinical study for patients with Alzheimer's Disease

Research Study Title

A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia

Purpose

The main purpose of this study is to evaluate the efficacy of the study drug known as lanabecestat in participants with mild Alzheimer's disease (AD) dementia.

To Learn more

Recruitment Details

Phase
3
Gender
All
Age
55 to 85 Years
Overall Status
Recruiting
Lead Sponsor
Eli Lilly and Company
Duration
38 Months
Facility Type
N/A
Compensation

Eligibility

All ages 55 Years to 85 Years

Inclusion Criteria:

  • Participant must meet the National Institute on Aging (NIA) and the Alzheimer's Association (AA) (NIA-AA) criteria for probable AD dementia.

  • MMSE score of 20 to 26 inclusive at screening visit.

  • For a diagnosis of mild AD dementia, participant must have a CDR global score of 0.5 or 1, with the memory box score ≥0.5 at screening.

  • Evidence of amyloid pathology.

  • The participant must have a reliable study partner with whom he/she cohabits or has regular contact.

Exclusion Criteria:

  • Significant and/or current neurological disease affecting the central nervous system, other than AD, that may affect cognition or ability to complete the study, including but not limited to, other dementias, repetitive head trauma, serious infection of the brain, Parkinson's disease, epilepsy, or cervicocranial vascular disease.

  • Participants with any current primary psychiatric diagnosis other than AD if, in the judgment of the investigator, the psychiatric disorder or symptom is likely to confound interpretation of drug effect, affect cognitive assessment, or affect the participant's ability to complete the study. Participants with history of schizophrenia or other chronic psychosis are excluded.

  • Within 1 year before the screening visit or between screening and randomization, any of the following: myocardial infarction; moderate or severe congestive heart failure, New York Heart Association class III or IV; hospitalization for, or symptoms of, unstable angina; syncope due to orthostatic hypotension or unexplained syncope; known significant structural heart disease (such as, significant valvular disease, hypertrophic cardiomyopathy); or hospitalization for arrhythmia.

  • Congenital QT prolongation.

  • Intermittent second- or third-degree atrioventricular (AV) heart block or AV dissociation or history of ventricular tachycardia.

  • A corrected QT (QTcF) interval measurement > 470 milliseconds (men and women) at screening (as determined at the investigational site).

  • History of malignant cancer within the last 5 years.

  • History of vitiligo and/or current evidence of post-inflammatory hypopigmentation.

  • Calculated creatinine clearance < 30 milliliters per minute (Cockcroft-Gault formula; Cockcroft and Gault 1976) at screening.

  • Currently enrolled in any other clinical trial involving an investigational product or any other type of medical research judged not to be scientifically or medically compatible with this study.

Site Locations (252)

Country State City Zip Facility and Contact
United States Arizona Phoenix 85004 Xenoscience
602-274-9500

Stephen Flitman
Principal Investigator
United States Arizona Phoenix 85013 St Josephs Hospital and Medical Center
602-406-4784

Marwan Sabbagh
Principal Investigator
United States Arizona Scottsdale 85258 Four Peaks Neurology
480-614-0707

Constantine Moschonas
Principal Investigator
United States Arizona Scottsdale 85260 Arizona Neurology
480-718-9241

Dennis Swearingen
Principal Investigator
United States Arizona Tucson 85718 Center for Neurosciences
520-320-2147

Michael Badruddoja
Principal Investigator
United States Arkansas Jonesboro 72401 NEA Baptist Clinical
870-934-1006

Kenneth Chan
Principal Investigator
United States Arkansas Springdale 72764 Woodland Research Northwest, LLC
479-927-3000

Fayz Hudefi
Principal Investigator
United States California Anaheim 92805 Advanced Research Center
714-493-7258

Steven Macina
Principal Investigator
United States California Carlsbad 92011 The Research Center of Southern California
760-732-0557

BENJAMIN FRISHBERG
Principal Investigator
United States California Costa Mesa 92626 WCCT Global
714-668-1500

Roginelli Yu
Principal Investigator
United States California Fresno 93710 Neuro-Pain Medical Center
559-437-9700

Perminder Bhatia
Principal Investigator
United States California Fullerton 92835 Neurology Center of North Orange County
714-879-7200

Johnson Moon
Principal Investigator
United States California Oxnard 93030 Pacific Neuroscience Medical Group
805-278-4148

James Sutton
Principal Investigator
United States California San Diego 92103-6204 California Research Foundation
619-291-2321

D BRANDON
Principal Investigator
United States California San Diego 92103 Pacific Research Network Inc
619-294-4302

Stephen Thein
Principal Investigator
United States California San Diego 92123 Sharp Mesa Vista Hospital
858-836-8355

MICHAEL PLOPPER
Principal Investigator
United States California San Francisco 94158 Univ of California San Francisco
415-476-0668

Adam Boxer
Principal Investigator
United States California Santa Ana 92705 Syrentis Clinical Research
714-542-3008 ext. 301

John Duffy
Principal Investigator
United States California Santa Clarita 91321 Care Access Research
661-388-0430

Surisham Dhillon
Principal Investigator
United States California Sherman Oaks 91403 California Neuroscience Research
818-990-2671

THOMASSHIOVITZ THOMAS SHIOVITZ
Principal Investigator
United States California Valencia 91355 Care Access Research
661-388-0397

Mehdi Meratee
Principal Investigator
United States California Walnut Creek 94598 University of California, Davis - Health Systems
916-734-5496

John Olichney
Principal Investigator
United States Connecticut Danbury 06810 Associated Neurologists, PC - Danbury
203-748-2551

Samuel Markind
Principal Investigator
United States Connecticut New Haven 06510 Yale University School of Medicine
203-764-8100

CHRIS VAN DYCK
Principal Investigator
United States Connecticut Norwalk 06851 Research Center fro Clinical Studies, Inc
203-838-0070

Bart Sloan
Principal Investigator
United States Florida Atlantis 33462 JEM Research Institute
561-968-2933

Mark Goldstein
Principal Investigator
United States Florida Clearwater 33755 Morton Plant Hospital
727-443-3295

Diana Pollock
Principal Investigator
United States Florida Delray Beach 33445 Brain Matters Research
561-374-8461

Mark Brody
Principal Investigator
United States Florida Delray Beach 33446 Cohen Medical Associates P.A.
561-496-7200

Robert Cohen
Principal Investigator
United States Florida Fort Myers 33912 Neuropsychiatric Research Center of Southwest Florida
239-939-7777 ext. 116

Frederick Schaerf
Principal Investigator
United States Florida Hialeah 33012 Indago Research & Health Center, Inc.
305-827-3335

Jose Cardona
Principal Investigator
United States Florida Hollywood 33021 Infinity Clinical Reserach . LLC
954-981-3850

Harvey Schwartz
Principal Investigator
United States Florida Jacksonville 32216 Jacksonville Center for Clinical Research
904-730-0101

Erin Doty
Principal Investigator
United States Florida Jacksonville 32224 Mayo Clinic of Jacksonville
904-953-7103

Neil Graff-Radford
Principal Investigator
United States Florida Merritt Island 32955 Gregory A. Kirk MD LLC
321-848-0770

Gregory Kirk
Principal Investigator
United States Florida Miami 33136 University of Miami
305-243-9068

B BAUMEL
Principal Investigator
United States Florida Miami 33155 Allied Biomedical Research Institute, Inc.
305-643-8400

Michael Pfeffer
Principal Investigator
United States Florida Orlando 32806 Compass Research
407-426-9299

Craig Curtis
Principal Investigator
United States Florida Pompano Beach 33064 Quantum Laboratories
954-786-7331

Jose De La Gandara
Principal Investigator
United States Florida Port Charlotte 33980 Charlotte Neurological Services
941-743-4987

Ramon Gil
Principal Investigator
United States Florida Sarasota 34239 Intercoastal Medical Group
941-330-1864 ext. 2

Mauricio Concha
Principal Investigator
United States Florida Tampa 33609 Axiom Research
813-353-9613

Susan Steen
Principal Investigator
United States Florida Tampa 33612 Johnnie B Byrd, Sr. Alzheimer's Center and Research Institut
813-974-4355

Amanda Smith
Principal Investigator
United States Georgia Atlanta 30329 Emory University
404-727-7220

Allan Levey
Principal Investigator
United States Georgia Atlanta 30331 Atlanta Center of Medical Research
404-881-5800

Robert Riesenberg
Principal Investigator
United States Georgia Augusta 30912 Georgia Regents University
706-721-2798

John Morgan
Principal Investigator
United States Georgia Columbus 31909 Medical Research Health and Education Foundation, Inc
706-653-8455

Jonathan Liss
Principal Investigator
United States Hawaii Honolulu 96817 Hawaii Medical Center
808-261-4476

Kore Liow
Principal Investigator
United States Idaho Meridian 83642 Advanced Clinical Research LLC
208-377-8653 ext. 105

Mark Turner
Principal Investigator
United States Indiana Avon 46123 American Health Network
317-745-8000 ext. 1077

Mark Benson
Principal Investigator
United States Indiana Indianapolis 46256 Josephson Wallack Munshower Neurology
317-537-6060

KRISTI GEORGE
Principal Investigator
United States Indiana Muncie 47304 American Health Network
801-365-1032

Jonathan Condit
Principal Investigator
United States Kansas Topeka 66606 Cotton O'Neil Clinic
785-368-0744

Scott Teeter
Principal Investigator
United States Kansas Wichita 67214 Via Christi Research, Inc.
316-291-4774

Paul Murphy
Principal Investigator
United States Kentucky Lexington 40503 Baptist Health Medical Group
859-260-4330

Greg Cooper
Principal Investigator
United States Kentucky Lexington 40513 Associates in Neurology, PSC
859-685-0684

Gregory Anderson
Principal Investigator
United States Maine Bangor 04401 Eastern Maine Medical Center
207-973-9043

Clifford Singer
Principal Investigator
United States Maine Scarborough 04074 Maine Neurology
207-883-1414

Eric Dinnerstein
Principal Investigator
United States Massachusetts Boston 02118 Boston University Medical Center
617-638-5678

Robert Stern
Principal Investigator
United States Massachusetts Plymouth 02360-4843 Donald S Marks
508-746-5060

Donald Marks
Principal Investigator
United States Massachusetts Winchester 01890 Alzheimers Disease Center
617-639-5006

Anil Nair
Principal Investigator
United States Michigan East Lansing 48824 Michigan State University
517-884-2482

Andrea Bozoki
Principal Investigator
United States Mississippi Hattiesburg 39401 Hattiesburg Clinic
601-268-5620

Ronald Schwartz
Principal Investigator
United States Missouri Saint Louis 63141 Clinical ResearchProfessionals
636-220-1200

Timothy Jennings
Principal Investigator
United States Nevada Las Vegas 89113 Las Vegas Medical Research
310-993-9118

Bharat Mocherla
Principal Investigator
United States New Jersey Toms River 08755 Advanced Memory Research Institute of New Jersey
732-341-9500

Sanjiv Sharma
Principal Investigator
United States New Jersey West Long Branch 07764 Neurology Specialists of Monmouth County
732-935-1850

Noah Gilson
Principal Investigator
United States New York New York 10016 New York University Medical Center
212-263-5845

Melanie Shulman
Principal Investigator
United States North Carolina Charlotte 28211 Behavioral Health Center Research
704-446-7504

Oleg Tcheremissine
Principal Investigator
United States North Carolina Raleigh 27607 Raleigh Neurology Associates
919-782-3456

Bradley Robottom
Principal Investigator
United States North Carolina Winston-Salem 27103 PMG Research of Winston-Salem, LLC
336-794-8165

Giles Crowell
Principal Investigator
United States Ohio Cleveland 44122 Rapid Medical Research Inc
212-682-0320

Mary Manning
Principal Investigator
United States Ohio Columbus 43210 Ohio State University Medical Center
614-293-8531

Douglas Scharre
Principal Investigator
United States Ohio Shaker Heights 44122 Insight Clinical Trials
216-526-1843

Deborah Gould
Principal Investigator
United States Oklahoma Oklahoma City 73112 Lynn Health Science Institute
405-602-3939

Carl Griffin
Principal Investigator
United States Oklahoma Oklahoma City 73116 Cutting Edge Research Group
405-603-8068

Willis Holloway
Principal Investigator
United States Oregon Corvallis 97330 The Corvallis Clinic P.C.
541-754-1150

Weijia Wang
Principal Investigator
United States Oregon Portland 97210 Summit Research Network Inc
503-972-9833

Scott Losk
Principal Investigator
United States Pennsylvania Jenkintown 19046 Clinical Trial Center, LLC, Psychiatry
215-884-1700

Marvin Kalafer
Principal Investigator
United States Pennsylvania Norristown 19401 Pearl Clinical Research Inc.
610-270-9571

Robert Pearlstein
Principal Investigator
United States Rhode Island East Providence 02914 Rhode Island Mood & Memory Research Institute
401-435-8950

John Stoukides
Principal Investigator
United States Rhode Island Providence 02903 Rhode Island Hospital
401-444-6440

Brian Ott
Principal Investigator
United States Rhode Island Providence 02906 Butler Hospital
401-455-6403

Stephen Salloway
Principal Investigator
United States South Carolina Charleston 29425 Medical University of South Carolina
843-792-3221

David Clark
Principal Investigator
United States South Carolina Greer 29650 Radiant Research
864-877-9239

William Ellison
Principal Investigator
United States South Carolina Port Royal 29935 Coastal Neurology PA
843-522-1420

Paul Mazzeo
Principal Investigator
United States Tennessee Kingsport 37660 Holston Medical Group Clinical Research
423-578-1546

David Morin
Principal Investigator
United States Texas Dallas 75248 University of Texas Southwestern Medical Center at Dallas
214-648-6321

Mary Quiceno
Principal Investigator
United States Texas Fort Worth 76107 Univ of North Texas Health Science Center
817-735-2193

Janice Knebl
Principal Investigator
United States Texas San Antonio 78229 Clinical Trials of Texas, Inc.
210-949-0122

Kate Glywasky
Principal Investigator
United States Texas San Antonio 78238 Texas Medical Research Associates, L.L.C.
210-521-7771

Patrick Peters
Principal Investigator
United States Utah Clinton 84015 Ericksen Research and Development
801-614-5501

Tyler Dixon
Principal Investigator
United States Washington Seattle 98104 Summit Research Network LLC
206-624-4587

JERRY STEIERT
Principal Investigator
United States Washington Wenatchee 98801 Wenatchee Valley Hospital & Clinics
509-665-5800

JOSEPH TORNABENE
Principal Investigator
United States Wisconsin Middleton 53562 Dean Foundation for Health Research and Education
608-827-2320

Anne Koplin
Principal Investigator
Belgium Brussels 1200 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Canada Calgary T2N 426 For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.
Eli Lilly and Company
Canada Gatineau J8T 8J1 For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.
Eli Lilly and Company
Canada Halifax B3S1M7 For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.
Eli Lilly and Company
Canada Ottawa K1N 5C8 For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.
Eli Lilly and Company
Canada Peterborough K9H2P4 For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.
Eli Lilly and Company
Canada Sherbrooke J1J 2G2 For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.
Eli Lilly and Company
Canada Sherbrooke J1J3H5 For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.
Eli Lilly and Company
Canada Toronto M3B2S7 For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.
Eli Lilly and Company
Canada Verdun H4H 1R3 For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.
Eli Lilly and Company
Canada West Vancouver V7T223 "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician."
Eli Lilly and Company
Czechia Brno 65691 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Czechia Chocen 565 01 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Czechia Choceň 56501 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Czechia Hradec Kralove 50009 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Czechia Kladno 27201 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Czechia Plzen 31200 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Czechia Praha 10 100 00 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Czechia Praha 4 14000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Czechia Praha 6 16000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Denmark Alborg 9100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Denmark Ballerup 2750 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Denmark Copenhagen 2100 CPH For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Denmark Vejle 7100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
France Amiens Cedex 1 80054 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
France Caen Cedex 14033 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
France Marseille 13385 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
France Nice 06100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
France Paris 75013 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
France Rennes Cedex 35064 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
France Saint Priest en Jarez 42270 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
France Strasbourg Cedex 67098 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
France Toulouse Cedex 31059 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
France Vandœuvre-lès-Nancy 54511 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
France Villejuif 94805 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Germany Baden 70178 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Germany Berlin 12209 MVZ LiO Berlin
493076896021

Brita Dorn
Principal Investigator
Germany Böblingen 71034 Nervenärztliche Gemeinschaftspraxis
4915170389535

Felix Bischof
Principal Investigator
Germany Hannover 30559 Diakovere Henriettenstift
495112893223

Klaus Hager
Principal Investigator
Germany Mannheim 68165 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Germany München 81377 Klinikum der Universität München Campus Großhadern
4989440046046

Katharina Bürger
Principal Investigator
Germany München 81675 Klinikum rechts der Isar der TU München
498941404262

Timo Grimmer
Principal Investigator
Germany Ostfildern 73760 Nervenarztpraxis Ostfildern
497113412021

Gerhard Roth
Principal Investigator
Germany Unterhaching 82008 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Germany Wuppertal 42282 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Italy Brescia 25123 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Italy Firenze 50134 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Italy Genova 16128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Italy Genova 16132 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Italy Napoli 80143 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Italy Pisa 56126 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Italy Ponderano 13875 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Italy Roma 00168 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Italy Roma 00185 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Aizuwakamatsu 965-8585 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Anjo-shi 446-8510 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Aomori 030-8553 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Bunkyo-ku 113-8431 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Chiba-shi 263-0043 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Hiroshima-shi 733-0864 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Kanzaki-gun 842-0192 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Kanzaki 8420192 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Kobe-shi 655-0037 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Kumamoto 861-8002 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Kyoto-Shi 600-8558 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Kyoto 6008558 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Musashino 180-8610 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Nagoya-shi 454-8502 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Nagoya-Shi 457-8511 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Nara-Shi 630-8305 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Nara 6348522 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Niigata-Ken 945-8585 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Osaka-Fu 565-0874 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Osaka-Shi 534-0021 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Osaka-shi 556-0015 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Otaki 739-0696 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Sapporo-shi 063-0005 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Shirakawa-shi 961-0021 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Shizuoka-shi 424-8636 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Tokyo 1138431 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Tokyo 1920071 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Toon-Shi 791-0295 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Uji-Shi 611-0021 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Yokohama 221-0801 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Yonago-shi 683-8605 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Yufu-shi 879-5593 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Japan Ōtaki 7390696 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Korea, Republic of Bucheon 14647 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Korea, Republic of Busan 49201 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Korea, Republic of Daegu 42415 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Korea, Republic of Goyang-si 13620 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Korea, Republic of Gyeonggi-do 13620 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Korea, Republic of Incheon 22332 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Korea, Republic of Seongnam-si 13620 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Korea, Republic of Seoul 02841 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Korea, Republic of Seoul 03080 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Korea, Republic of Seoul 05030 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Korea, Republic of Seoul 06351 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Mexico Durango 34000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Mexico Mexico City 01710 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Mexico Mexico City 03100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Mexico Mexico City 11000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Mexico Monterrey 64000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Mexico Monterrey 64460 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Mexico Monterrey 64620 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Mexico Monterrey 64710 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Mexico Tlalnepantla 54055 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Netherlands Almere 1311 RL For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Netherlands Amsterdam 1081 GM For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Netherlands Utrecht 3511 NH For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Netherlands Zwolle 8025 AB For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Poland Białystok 15-732 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Poland Gdansk 80-952 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Poland Katowice 40749 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Poland Kłodzko 57-300 "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician."
Eli Lilly and Company
Poland Lubin 53 139 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Poland Lublin 20-582 "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician."
Eli Lilly and Company
Poland Rzeszow 35-055 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Poland Szczecin 70-111 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Poland Warszawa 01-697 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Portugal Amadora 2700-351 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Portugal Coimbra 3000-075 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Russian Federation Kazan 420064 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Russian Federation Kemerovo 650066 SIH Kemerovo Regional Clinical Hosptial
73842396423

Elena Arefyeva
Principal Investigator
Russian Federation Krasnoyarsk 660049 FSBIH Siberian Clinical Center of FMBA
73912272327

Dmitry Pokhabov
Principal Investigator
Russian Federation Novosibirsk 630091 LLC City Neurological Centre Sibneuromed
73832251789

Olga Doronina
Principal Investigator
Russian Federation Novosibirsk 630091 Novosibirsk State Medical University
73832292620

Elena Vostrikova
Principal Investigator
Russian Federation Rostov-on-Don 344010 LLC Treatment and Rehabilitation
78632674815

Olga Bukhanovskaya
Principal Investigator
Russian Federation Smolensk 214018 RSBIH Smolensk Regional Clinical Hospital
74812621157

Maria Strachunskaya
Principal Investigator
Russian Federation Smolensk 644024 Ultramed
79136882778

Tatyana Ivanova
Principal Investigator
Russian Federation St Petersburg 192019 Bekhterev Psyconeurological Institute
71825677264

Vladimir Mikhailov
Principal Investigator
Russian Federation St. Petersburg 194291 Central Medical Sanitary Hospital #122
78125588797

Alexander Elchaninov
Principal Investigator
Spain Barcelona 08003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Spain Barcelona 08028 "For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician."
Eli Lilly and Company
Spain Barcelona 08028 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Spain Donostia 20009 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Spain Plasencia 10600 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Spain San Vicente del Raspeig 03690 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Spain Sant Cugat del Valles 08190 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Spain Terrassa 08221 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Spain Valencia 46026 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Taiwan Changhua 500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Taiwan Douliou City 640 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Taiwan Kaohsiung 807 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Taiwan Kaohsiung 83301 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Taiwan Sindian City 23148 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Taiwan Tainan 70403 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Taiwan Taipei 11217 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Taiwan Taipei 23561 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
Taiwan Taoyuan City 33305 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
United Kingdom Exeter EX2 5DW For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
United Kingdom Greater London W1G9JF For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
United Kingdom Guildford GU2 7YD For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
United Kingdom Perth PH2 7BH For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
United Kingdom Plymouth PL6 8BT For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
United Kingdom Scotland G20 0XA For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company
United Kingdom Swindon SN3 6BW For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eli Lilly and Company

Contact

There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or
1-317-615-4559

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.